Going Pro to enhance T-cell immunogenicity: Easy as π?

Relapse or Eradication of Cancer Is Predicted by Peptide-Major Histocompatibility Complex Affinity

(2013) Boris Engels et al.   CANCER CELL

Proline substitution independently enhances H-2Dbcomplex stabilization and TCR recognition of melanoma-associated peptides

(2013) Hannes Uchtenhagen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Discovering naturally processed antigenic determinants that confer protective T cell immunity

(2013) Pavlo Gilchuk et al.   JOURNAL OF CLINICAL INVESTIGATION

Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity

(2012) Mikkel Harndahl et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I

(2012) S. R. Starck et al.   SCIENCE

Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation

(2011) S. Apcher et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals

(2011) C. Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Running the gauntlet: from peptide generation to antigen presentation by MHC class I

(2011) P. M. Saunders et al.   TISSUE ANTIGENS

DRiPs solidify: progress in understanding endogenous MHC class I antigen processing

(2011) Jonathan W. Yewdell   TRENDS IN IMMUNOLOGY

RNA Polymerase II Inhibitors Dissociate Antigenic Peptide Generation from Normal Viral Protein Synthesis: A Role for Nuclear Translation in Defective Ribosomal Product Synthesis?

(2010) B. P. Dolan et al.   JOURNAL OF IMMUNOLOGY

Design of Agonistic Altered Peptides for the Robust Induction of CTL Directed towards H-2Db in Complex with the Melanoma-Associated Epitope gp100

(2009) M. J.B. van Stipdonk et al.   CANCER RESEARCH